Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Drug Discov Ther ; 14(5): 232-238, 2020 Nov 04.
Article in English | MEDLINE | ID: mdl-33116041

ABSTRACT

The objective of this study was to explore the factors associated symptoms of depression among pregnant women with gestational diabetes mellitus (GDM) in Japan. This cross-sectional study was conducted at a hospital in Toyota, Japan, from January 2015 to June 2016. Pregnant women who visited the hospital and were diagnosed with GDM in the second trimester were enrolled. We analyzed depression symptoms using the Centers for Epidemiological Studies Depression Scale (CES-D) and considered related factors of depression symptoms, such as dietary intake and daily walking. Dietary intake during the past month was assessed using a brief self-administered diet history questionnaire, and daily walking was assessed using an accelerometer. The prevalence rate for GDM was 8.8%, and 25 pregnant women with GDM were analyzed. The CES-D was not significantly correlated with pre-pregnancy BMI, postprandial plasma glucose, hemoglobin A1c, and the number of steps walked. In contrast, a significant negative correlation was observed between the CES-D score and intake of fish with bones, simmered fish, pickles, green leaves, mushrooms, and green tea. Furthermore, a significant positive correlation was found between Coke® and CES-D scores. For nutrient intake, a significant negative correlation was found between the CES-D score and vitamin K, folate, and ß-carotene levels. The present study suggests that depression symptoms among pregnant women with GDM in the second trimester may be associated with diet.


Subject(s)
Depression/etiology , Diabetes, Gestational/psychology , Diet/psychology , Pregnancy Complications/psychology , Pregnant Women/psychology , Adult , Cross-Sectional Studies , Depression/diagnosis , Depression/epidemiology , Diabetes, Gestational/diagnosis , Diabetes, Gestational/epidemiology , Diet/adverse effects , Eating/psychology , Female , Humans , Japan/epidemiology , Pregnancy , Pregnancy Complications/epidemiology , Pregnancy Trimester, Second , Prenatal Nutritional Physiological Phenomena , Prevalence , Surveys and Questionnaires/statistics & numerical data , Walking/psychology
2.
J Obstet Gynaecol Res ; 44(9): 1731-1738, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29974564

ABSTRACT

AIM: This study evaluated the usefulness of daily walking for gestational diabetes mellitus (GDM) management by analyzing the relationship between daily walking and glucose tolerance in pregnant women with GDM who were in the second trimester. METHODS: This longitudinal study was conducted at TOYOTA Memorial Hospital in Toyota, Japan, from January 2015 to June 2016. Pregnant women with GDM wore accelerometers on the waist for 7-12 weeks. RESULTS: Seventy-three women with GDM were included in the present study; data collected from 24 women were analyzed. The estimated number of steps walked daily showed a significant positive correlation (r = 0.798, P = 0.000) with energy expenditure related to physical activity. There was a significant negative correlation (r = -0.603, P = 0.014) between the post- to pre-research casual glucose level (CGL) ratio and the number of steps walked daily. No significant correlation (r = -0.004, P = 0.986) was detected between the ratio of hemoglobin A1c and the number of steps taken. When the study was completed, the 11 participants who walked ≥6000 steps/day showed significantly lower CGL (95 + 10 mg/dL [mean + SD]) than the 13 participants in the <6000 steps/day group (111 + 18 mg/dL) (P = 0.013). CONCLUSION: Simple walking for light intensity physical activity is effective for controlling the CGL in pregnant women with GDM. We recommend that pregnant women with GDM should walk a minimum of 6000 steps/day.


Subject(s)
Diabetes, Gestational/therapy , Exercise Therapy/methods , Outcome Assessment, Health Care , Walking/physiology , Adult , Female , Humans , Longitudinal Studies , Pregnancy , Pregnancy Trimester, Second
3.
Intern Med ; 52(10): 1073-8, 2013.
Article in English | MEDLINE | ID: mdl-23676593

ABSTRACT

We herein present the case of a 53-year-old patient with adrenocorticotropin-independent macronodular adrenocortical hyperplasia (AIMAH), which is a rare form of Cushing syndrome. He had hypercortisolemia and bilateral macronodular adrenal glands with a left side predominance. The administration of vasopressin significantly increased the plasma cortisol level (1.9-fold). Following left adrenalectomy, the patient's hypercortisolemia significantly improved and vasopressin responsiveness was lost, suggesting that the responsiveness originated from the resected left adrenal gland. The marked difference in vasopressin responsiveness between the adrenals corresponded with their asymmetrical size and function. Evaluating the differences in the vasopressin sensitivity may therefore be helpful for understanding the progression of AIMAH.


Subject(s)
Adenoma/physiopathology , Adrenal Cortex Neoplasms/physiopathology , Adrenal Cortex/drug effects , Cushing Syndrome/physiopathology , Receptors, Vasopressin/drug effects , Vasopressins/pharmacology , Adenoma/pathology , Adenoma/surgery , Adrenal Cortex/metabolism , Adrenal Cortex/pathology , Adrenal Cortex Neoplasms/pathology , Adrenal Cortex Neoplasms/surgery , Adrenalectomy , Adrenocorticotropic Hormone/metabolism , Cushing Syndrome/blood , Cushing Syndrome/complications , Cushing Syndrome/surgery , Deamino Arginine Vasopressin , Dexamethasone , Diabetes Mellitus, Type 2/etiology , Glucose Tolerance Test , Gonadotropin-Releasing Hormone , Humans , Hydrocortisone/metabolism , Hypertriglyceridemia/etiology , Laparoscopy , Male , Middle Aged , Organ Size , Thyrotropin-Releasing Hormone
4.
Eur J Endocrinol ; 168(2): 169-75, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23132697

ABSTRACT

CONTEXT: Pseudohypoparathyroidism type Ib (PHP-Ib) is a rare disorder resulting from genetic and epigenetic aberrations in the GNAS complex. PHP-Ib, usually defined by renal resistance to parathyroid hormone, is due to a maternal loss of GNAS exon A/B methylation and leads to decreased expression of the stimulatory G protein α (Gsα) in specific tissues. OBJECTIVE: To clarify the usefulness of methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), we evaluated genetic and epigenetic changes of the GNAS locus in Japanese PHP-Ib patients. DESIGN: Retrospective case series. PATIENTS: We studied 13 subjects with PHP-Ib (three families with eight affected members and one unaffected member and four sporadic cases). MEASUREMENTS: The methylation status of GNAS differentially methylated regions (DMRs) was evaluated using MS-MLPA. The main outcome measure was the presence of deletion mutations in the GNAS locus and STX16, which were assessed using MLPA. RESULTS: In all familial PHP-Ib cases, a ~3 kb deletion of STX16 and demethylation of the A/B domain were identified. In contrast, no deletion was detected throughout the entire GNAS locus region in the sporadic cases. Broad methylation abnormalities were observed in the GNAS DMRs. CONCLUSIONS: MS-MLPA allows for precise and rapid analysis of the methylation status in GNAS DMRs as well as the detection of microdeletion mutations in PHP-Ib. Results confirm the previous findings in this disorder and demonstrate that this method is valuable for the genetic evaluation and visualizing the methylation status. The MS-MLPA assay is a useful tool that may facilitate making the molecular diagnosis of PHP-Ib.


Subject(s)
Epigenesis, Genetic , GTP-Binding Protein alpha Subunits, Gs/genetics , Pseudohypoparathyroidism/genetics , Chromogranins , DNA Methylation , Female , Genomic Imprinting , Humans , Male , Multiplex Polymerase Chain Reaction , Retrospective Studies , Sequence Deletion
SELECTION OF CITATIONS
SEARCH DETAIL
...